Search Results - "Burakov AM"

Safety and efficacy of ketamine for the treatment of patients with alcohol use disorder: a systematic review.

Authors: Rathore, Bhagwat Singh Singh, Swarndeep Gupta, Manushree et al.

Source: American Journal of Drug & Alcohol Abuse. 2025, Vol. 51 Issue 5, p563-576. 14p.

Non-invasive brain stimulation lighting the human life quality's bulb.

Authors: Zhang, Tiechen Jing, Xiaofeng Cao, Qiongfang et al.

Source: Brain-Apparatus Communication: A Journal of Bacomics. Dec2025, Vol. 4 Issue 1, p1-23. 23p.

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review.

Authors: Piper, Theodore Small, Francesca Brown, Sam et al.

Source: Addiction. Jan2025, p1. 24p. 1 Illustration.

Empirically contrasting urine drug screening‐based opioid use disorder treatment outcome definitions.

Authors: Brandt, Laura Odom, Gabriel J. Hu, Mei‐Chen et al.

Source: Addiction. Jul2024, Vol. 119 Issue 7, p1289-1300.

Intravenous ketamine for severe alcohol use disorder at Moi Teaching & Referral Hospital, Kenya: a case report.

Authors: Jaguga, Florence Kirwa, Philip Gakinya, Benson et al.

Source: Substance Abuse Treatment, Prevention & Policy. 2/17/2023, Vol. 18 Issue 1, p1-10. 10p.

Ketamine in Substance Use Disorder Treatment: A Narrative Review.

Authors: Famuła, Anna Radoszewski, Jakub Czerwiec, Tomasz et al.

Source: Alpha Psychiatry. Apr2024, Vol. 25 Issue 2, p206-211. 6p.

Xenon gas as a potential treatment for opioid use disorder, alcohol use disorder, and related disorders.

Authors: Kaufman, Marc J. Meloni, Edward G.

Source: Medical Gas Research. Jun2025, Vol. 15 Issue 2, p234-253. 20p.

Ketamine for depressive symptoms: A retrospective chart review of a private ketamine clinic.

Authors: Juby, Vidette M. Paruk, Saaeda Tomita, Mitsuaki et al.

Source: South African Journal of Psychiatry. 2024, Vol. 30, p1-7. 7p.

Low dose baclofen and standard dose acamprosate had comparable changes in brain glutamate, brain Gamma amino butyric acid (GABA) and craving among patients with alcohol dependence syndrome: A 1H-MRS based open label randomized study.

Authors: Kesan, Akhil Dey, Pranjal Khanra, Sourav et al.

Source: Industrial Psychiatry Journal. Jan-Apr2025, Vol. 34 Issue 1, p25-31. 7p.

Capturing drug use patterns at a glance: An n-ary word sufficient statistic for repeated univariate categorical values.

Authors: Odom, Gabriel J. Brandt, Laura Castro, Clinton et al.

Source: PLoS ONE. 9/8/2023, Vol. 18 Issue 9, p1-13. 13p.

Ketamine-facilitated behavioral treatment for cannabis use disorder: A proof of concept study.

Authors: Azhari, Nour Hu, Helen O'Malley, Kate Y. et al.

Source: American Journal of Drug & Alcohol Abuse. 2021, Vol. 47 Issue 1, p92-97.

Alteration in AMPA receptor subunit expression and receptor binding among patients with addictive disorders: A systematic review of human postmortem studies.

Authors: Ueno, Fumihiko Suzuki, Takefumi Nakajima, Shinichiro et al.

Source: Neuropsychopharmacology Reports. Sep2019, Vol. 39 Issue 3, p148-155. 8p.

Comparison of the effect of naltrexone with or without fluoxetine for preventing relapse to opioid addiction.

Authors: Soltanifar, Azadeh Ashari, Arezou

Source: Journal of Fundamentals of Mental Health. Sep/Oct2024, Vol. 26 Issue 5, p285-289. 5p.

A case series of group-based ketamine-assisted psychotherapy for patients in residential treatment for eating disorders with comorbid depression and anxiety disorders.

Authors: Robison, Reid Lafrance, Adele Brendle, Madeline et al.

Source: Journal of Eating Disorders. 5/6/2022, Vol. 10 Issue 1, p1-9. 9p.

The Relationship Between Ketamine and Memory Impairment: A Systematic Review.

Alternate Title: Ketamin ve Bellek Bozuklukları Arasındaki İlişki: Bir Sistematik Derleme.

Authors: Al-badran, Ghaith¹ psy.g.albadran@gmail.com

Source: Cumhuriyet Medical Journal. Jun2024, Vol. 46 Issue 2, p84-98. 15p.

Baclofen for alcohol use disorder—a systematic meta‐analysis.

Authors: Bschor, T. Henssler, J. Müller, M. et al.

Source: Acta Psychiatrica Scandinavica. Sep2018, Vol. 138 Issue 3, p232-242. 11p. 1 Diagram, 3 Charts, 1 Graph.

Subjects: Alcoholism treatment, Drug efficacy, Baclofen, Alcohol drinking, Heterogeneity, Meta-analysis, Therapeutics

The use of ketamine to cope with depression and post-traumatic stress disorder: A qualitative analysis of the discourses posted on a popular online forum.

Authors: Chaves, Tharcila V. Wilffert, Bob Sanchez, Zila M.

Source: American Journal of Drug & Alcohol Abuse. 2020, Vol. 46 Issue 5, p613-624.

Lamotrigine and hemodialysis in bipolar disorder: case analysis of dosing strategy with literature review.

Authors: Kaufman, Kenneth R¹ (AUTHOR)

Source: Bipolar Disorders. Jun2010, Vol. 12 Issue 4, p446-449. 4p.

Potential uses of naltrexone in emergency department patients with opioid use disorder.

Authors: Bradley, Evan Stuart Liss, David Carreiro, Stephanie Pepper et al.

Source: Clinical Toxicology (15563650). Sep2019, Vol. 57 Issue 9, p753-759. 7p.

Anhedonia, depression, anxiety, and craving in opiate dependent patients stabilized on oral naltrexone or an extended release naltrexone implant.

Authors: Krupitsky, Evgeny Zvartau, Edwin Blokhina, Elena et al.

Source: American Journal of Drug & Alcohol Abuse. Sep2016, Vol. 42 Issue 5, p614-620.